Gilead Sciences (GILD) Change in Inventory (2009 - 2026)

Gilead Sciences (GILD) has reported Change in Inventory for 18 consecutive years, with $52.0 million the latest figure, recorded in Q1 2026.

• Change in Inventory for Q1 2026 came in at $52.0 million, down 76.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $865.0 million (up 43.21% YoY), and the FY2025 annual result was $1.0 billion, up 143.19% from the prior year.
• Change in Inventory was $52.0 million for Q1 2026 at Gilead Sciences, down from $123.0 million in the prior quarter.
• Over five years, Change in Inventory peaked at $515.0 million in Q3 2025 and troughed at -$53.0 million in Q1 2022.
• Average Change in Inventory over 5 years is $156.8 million, with a median of $123.0 million recorded in 2025.
• Year-over-year, Change in Inventory tumbled 176.81% in 2022 and surged 2925.0% in 2023.
• Over 5 years, Change in Inventory stood at $276.0 million in 2022, then climbed by 11.23% to $307.0 million in 2023, then retreated by 26.38% to $226.0 million in 2024, then plunged by 45.58% to $123.0 million in 2025, then tumbled by 57.72% to $52.0 million in 2026.
• Per Business Quant data, the three most recent Change in Inventory figures were $52.0 million in Q1 2026, $123.0 million in Q4 2025, and $515.0 million in Q3 2025.